Dr reddy share price

Dr. Reddy's Laboratories Ltd.: Share Price, Stock Analysis, Annual Report | Value Research Dr. Reddy's Laboratories Ltd.: Share Price, Stock Analysis, Annual Report | Value Research https://www.valueresearchonline.com/stocks/41846/dr-reddy-s-laboratories-ltd/ Get Dr. Reddy's Laboratories Ltd.'s stock analysis, price valuation, corporate actions, and financials from India's independent mutual fund research house. Business Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand name or as a generic finished dosages with therapeutic equivalence to branded formulations. This segment also engages in the biologics business. The PSAI segment manufactures and markets active pharmaceutical ingredients and intermediates, which are principal ingredients for finished pharmaceutical products. This segment also provides contract research services; and manufactures and sells active pharmaceutical ingredients and steroids in accordance with the specific customer requirements. Its Proprietary Products segment focuses on the research and development of differentiated formulations. The Others segment engages in developing therapies...

Key Data • Open ₹4,693.90 • Day Range 4,690.00 - 4,857.75 • 52 Week Range 3,996.10 - 4,987.00 • Market Cap ₹781.8B • Shares Outstanding 166.54M • Public Float 115.44M • Beta N/A • Rev. per Employee ₹9.507M • P/E Ratio 17.74 • EPS ₹270.84 • Yield 0.83% • Dividend ₹40.00 • Ex-Dividend Date Jul 11, 2023 • Short Interest N/A • % of Float Shorted N/A • Average Volume 9.92K Dr. Reddy's Laboratories Ltd. Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active Ingredients, Proprietary Products, and Others. The Global Generics segment consists of manufacturing and marketing of prescription and over-the-counter finished pharmaceutical products ready for consumption by the patient, marketed under a brand name or as generic finished dosages with therapeutic equivalence to branded formulations. The Pharmaceutical Services & Active Ingredients segment is comprised of manufacturing and marketing of active pharmaceutical ingredients and intermediates, also known as API, which are the principal ingredients for finished pharmaceutical products. The Proprietary Products segment focuses on research and development of differentiated formulations. The Others segment includes the operations of the subsidiary of the company. The company was founded by Kallam Anji Reddy on February 24, 1984 and is headquartered in Hyderabad, India.

The bid & ask refers to the price that an investor is willing to buy or sell a stock. The bid is the highest amount that a buyer is currently willing to pay, whereas the ask is the lowest ... Read More. amount that a seller is currently willing to sell. The numbers next to the bid/ask are the “ size”. The bid size displays the total amount of desired shares to buy at that price, and the ask size is the number of shares offered for sale at that price. The data displayed in the quote bar updates every 3 seconds; allowing you to monitor prices in real-time. The bid-ask spread can indicate a stock’s liquidity, which is how easy it is to buy and sell in the marketplace. Often, a smaller spread suggests higher liquidity, meaning more buyers and sellers in the market are willing to negotiate. In contrast, a larger spread suggests lower liquidity, as there are fewer investors willing to negotiate. You can use the bid-ask spread to determine whether to place a market order or limit order when trading, helping you to optimize your price and have a successful order execution. Real-time bid and ask information is powered by Nasdaq Basic, a premier market data solution. This data feed is available via Nasdaq Data Link APIs; to learn more about subscribing, visit Nasdaq Data Link's products page. ... Read Less. Label Value Investors may trade in the Pre-Market (4:00-9:30 a.m. ET) and the After Hours Market (4:00-8:00 p.m. ET). Participation from Market Makers and ECNs is strictly volunt...

• 5:28p ‘It feels like a heavy burden’: My husband asked me to sell my $14,000 engagement ring to pay off our debt. Is he asking too much? • 5:26p Anheuser-Busch InBev S.A. ADR rises Thursday, outperforms market • 5:25p Bank of America Corp. stock rises Thursday, still underperforms market • 5:25p Which is worse: Lying about money or losing it? • 5:25p Amazon.com Inc. stock rises Thursday, still underperforms market • 5:24p Apple Inc. stock rises Thursday, still underperforms market • 5:23p Cabot Corp.’s stock falls 10% after chemicals maker sees ‘soft’ global demand • 5:17p Ticketmaster and Live Nation plan to show ‘upfront all-in pricing’ in response to Biden’s push against junk fees • 5:17p I-95 collapse could impact retailers’ holiday season plans and freight rates, experts warn • 5:11p Your family’s meat might not be antibiotic-free, despite what it says on the label • • to be replaced Key Data • Open $58.53 • Day Range 58.49 - 59.52 • 52 Week Range 49.80 - 61.40 • Market Cap $9.52B • Shares Outstanding 166.54M • Public Float 166.53M • Beta 0.49 • Rev. per Employee $118.30K • P/E Ratio 17.60 • EPS $3.37 • Yield 0.70% • Dividend $0.32 • Ex-Dividend Date Aug 1, 2022 • Short Interest 1.89M 05/31/23 • % of Float Shorted 1.13% • Average Volume 247.9K Dr. Reddy's Laboratories Ltd. ADR Dr. Reddy's Laboratories Ltd. engages in the manufacture and marketing of pharmaceutical products. It operates through the following segments: Global Generics, Pharmaceutical Services & Active...